CARTRIDGE DEVICE FOR A MEASURING SYSTEM FOR MEASURING VISCOELASTIC CHARACTERISTICS OF A SAMPLE LIQUID, A CORRESPONDING MEASURING SYSTEM, AND A CORRESPONDING METHOD
20190353672 ยท 2019-11-21
Assignee
Inventors
Cpc classification
B01L2300/0636
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0627
PERFORMING OPERATIONS; TRANSPORTING
B01L2200/10
PERFORMING OPERATIONS; TRANSPORTING
G01N11/00
PHYSICS
B01L3/502
PERFORMING OPERATIONS; TRANSPORTING
G01N33/86
PHYSICS
B01L2400/0475
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0861
PERFORMING OPERATIONS; TRANSPORTING
B01L3/52
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/087
PERFORMING OPERATIONS; TRANSPORTING
International classification
G01N33/86
PHYSICS
B01L3/00
PERFORMING OPERATIONS; TRANSPORTING
G01N11/00
PHYSICS
Abstract
The present invention is directed to a cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, in particular a blood sample, comprising a cartridge body having at least one measurement cavity formed therein and having at least one probe element arranged in said at least one measurement cavity for performing a test on said sample liquid; and a cover being attachable on said cartridge body; wherein said cover covers at least partially said at least one measurement cavity and forms a retaining element for retaining said probe element in a predetermined position within said at least one measurement cavity. The invention is directed to a measurement system and a method for measuring viscoelastic characteristics of a sample liquid.
Claims
1. A system for evaluation of hemostasis comprising: a plurality of test chambers, including a first test chamber and a second test chamber, wherein each of the plurality of test chambers comprises a reagent or a combination of reagents, and wherein each of the plurality of test chambers is configured to receive blood of a test sample and to be interrogated to determine a hemostatic parameter of the blood received therein; one or more transducers for transmitting energy into one or more test chamber and for receiving reflected energy from the chamber and the sample therein; and control apparatus configured to determine the hemostatic parameters in parallel from signals from the one or more transducers; wherein the first chamber comprises a first reagent or a first combination of reagents that interact with the blood received therein, wherein the first reagent, or a reagent included in the first combination of reagents, is an activator of coagulation; and wherein the second chamber comprises a second combination of reagents that interact with blood of the test sample received therein, the second combination of reagents including an activator of coagulation and a reagent, or a combination of reagents, configured to inhibit platelet functions.
2. The system of claim 1, wherein the control apparatus is configured to determine a clotting time for one or more of (i) intrinsic activation or (ii) extrinsic activation.
3. The system of claim 1, wherein the control apparatus is configured to determine at least one parameter assessing the intrinsic pathway, the extrinsic pathway, platelet function, fibrinogen and/or lysis.
4. The system of claim 1, wherein the control apparatus is configured to determine at least one parameter from the group consisting of a clotting time for extrinsic activation or intrinsic activation, a comparison of clot firmness for activated coagulation tests with and without a thrombocyte suppression and time to lysis for extrinsic activation.
5. The system of claim 1, wherein at least one of the first reagent or the first combination of reagents and the second combination of reagents is provided in solid form prior to interacting with the test sample.
6. The system of claim 1, comprising a fluid pathway having an inlet for receiving the test sample, wherein the fluid pathway is in fluid communication with at least one test chamber to deliver the test sample, or a portion thereof, to one or more of the test chambers.
7. The system of claim 6, wherein at least a portion of the fluid pathway comprises a plastic material.
8. The system of claim 6, wherein the fluid pathway and the plurality of test chambers form a portion of a cartridge, wherein a portion of the cartridge is a plastic material.
9. The system of claim 6, wherein the test sample is mixed with the reagent or the combination of regents prior to being delivered into the test chamber.
10. The system of claim 1, wherein the plurality of test chambers form a part of a cartridge.
11. The system of claim 1, wherein a measuring system is configured to securely receive and hold in position a housing that defines the plurality of test chambers.
12. The system of claim 1, wherein a measuring system is configured to receive a housing that defines the plurality of test chambers and to securely position the housing in a predefined orientation.
13. The system of claim 1, wherein the system is capable of assessing components of hemostasis that include plasma coagulation factors, platelets, fibrinogen, and fibrinolytic factors of the plasma.
14. The system of claim 1, wherein the one or more transducers include a light emitter and detector.
15. The system of claim 1, wherein the system is capable of assessing components of hemostasis that include combined effects of coagulation, platelets, and fibrinolysis.
16. The system of claim 1, wherein the control apparatus is configured to determine the hemostatic parameters based on signals generated from induced displacement of the test sample produced by the one or more transducers.
17. The system of claim 1, wherein the first reagent or first combination of reagents is INTEM or EXTEM and wherein the second combination of reagents is FIBTEM.
18. The system of claim 1, wherein the second combination of reagents is FIBTEM.
19. A system for evaluation of hemostasis comprising: a plurality of test chambers, including a first test chamber and a second test chamber, wherein each of the plurality of test chambers comprises a reagent or combination of reagents, and wherein each of the plurality of test chambers is configured to receive blood of a test sample and to be interrogated to determine a hemostatic parameter of the blood received therein; one or more transducers for transmitting energy into one or more test chamber and for receiving reflected energy from the chamber and the sample therein; and control apparatus configured to determine the hemostatic parameters from signals from the one or more transducers and to determine a curve associated with a viscoelastic property of the blood of each test sample, the curve being generated from the interrogation as a function of time; wherein the first test chamber comprises a first reagent or a first combination of reagents that interact with the blood of the test sample received therein, wherein the first reagent, or at least one reagent included in the first combination of reagents, is an activator of coagulation; and wherein the second test chamber comprises a second combination of reagents that interact with blood of the test sample received therein, the second combination of reagents including an activator of coagulation and a reagent, or a combination of reagents, configured to cause a reduction in measurable changes in clot mechanical properties of the test sample when the test sample is interrogated by the one or more transducers.
20. The system of claim 19, wherein the one or more transducers include a light emitter and detector.
21. A system for evaluation of hemostasis comprising: a plurality of measurement cavities, including a first measurement cavity and a second measurement cavity, wherein each of the plurality of measurement cavities comprises a reagent or a combination of reagents, and wherein each of the plurality of measurement cavities is configured to receive blood of a test sample and to be interrogated to determine a hemostatic parameter of the blood received therein; measurement apparatus for transmitting energy into a measurement cavity and for receiving reflected energy from the cavity and the sample therein; wherein the first measurement cavity comprises a first reagent or a first combination of reagents that interact with the blood received therein, wherein the first reagent, or a reagent included in the first combination of reagents, is an activator of coagulation; and wherein the second measurement cavity comprises a second combination of reagents that interact with blood of the test sample received therein, the second combination of reagents including an activator of coagulation and a reagent, or a combination of reagents, configured to suppress thrombocyte function.
22. The system of claim 21 further comprising control apparatus configured to determine the hemostatic parameters from signals from the measurement apparatus and to perform at least three measurements in parallel.
23. The system of claim 22, wherein the plurality of measurement cavities and a fluid pathway having an inlet for receiving a test sample form a part of a cartridge, wherein the fluid pathway is in fluid communication with at least one measurement cavity to deliver the test sample, or a portion thereof, to one or more of the measurement cavities, wherein at least a portion of the cartridge comprises a plastic material.
24. The system of claim 22, wherein the plurality of measurement cavities comprises a plastic material.
25. The system of claim 21 further comprising control apparatus control apparatus configured to determine the hemostatic parameters in parallel from signals from the measurement apparatus.
26. The system of claim 21 further comprising control apparatus configured to determine the hemostatic parameters from signals from the measurement apparatus and to determine a curve associated with a viscoelastic property of the blood of each test sample, the curve being generated from the interrogation as a function of time.
27. The system of claim 21 wherein the each of the measurement cavities includes an integrally formed reagent cavity.
28. An apparatus for evaluation of hemostasis, comprising: a housing that is configured to couple to a system, wherein the system comprises measurement apparatus for each of a plurality of measurement cavities, wherein the system comprises control apparatus to direct measurement apparatus associated with each of the plurality of measurement cavities in the interrogation of the test sample to determine at least one viscoelastic property of the test sample; the plurality of measurement cavities, including a first measurement cavity, a second measurement cavity, and a third measurement cavity, that are each at least partially defined by the housing; and a fluid pathway having an inlet, defined by the housing, and from which an external vessel establishes fluid communication, to receive a test sample, wherein the fluid pathway is in fluid communication with the first measurement cavity, the second measurement cavity, and the third measurement cavity to deliver the test sample, or a portion thereof, to the first measurement cavity, the second measurement cavity, and the third measurement cavity, wherein each of the plurality of measurement cavities comprises a reagent or combination of reagents, and wherein each of the plurality of measurement cavities, including the first, second, and third measurement cavities, is configured to receive, via the fluid pathway, blood of a test sample to be interrogated to determine a plurality of hemostatic parameters; wherein the first measurement cavity comprises a first reagent or a first combination of reagents that interact with the blood received therein, wherein the first reagent, or a reagent included in the first combination of reagents, is configured to activate coagulation via extrinsic or intrinsic pathway; wherein the second measurement cavity comprises a second combination of reagents that interact with blood of the test sample received therein, wherein the second combination of reagents includes i) a reagent, or a combination of reagents, configured to activate coagulation and ii) a reagent, or a combination of reagents, configured to suppress thrombocyte contraction; and wherein the third measurement cavity comprises a third reagent or a third combination of reagents that interact with the blood received therein, wherein the third reagent, or a reagent included in the third combination of reagents, is configured to activate coagulation via the extrinsic or intrinsic pathway.
29. The apparatus of claim 28 wherein the each of the measurement cavities includes an integrally formed reagent cavity.
30. The apparatus of claim 28, wherein the housing forms a cartridge comprising the plurality of measurement cavities and the fluid pathway, wherein at least a portion of the cartridge is made from a plastic material.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0061] The figures are showing the following:
[0062]
[0063]
[0064]
[0065]
[0066]
[0067]
[0068]
[0069]
[0070]
[0071]
[0072]
[0073]
[0074]
[0075]
[0076]
[0077]
[0078]
[0079]
[0080]
[0081]
[0082]
[0083]
[0084]
[0085]
DESCRIPTION OF EXEMPLARY EMBODIMENTS Parts and components having same functions are depicted with same references.
[0086] Prior to a detailed description of the preferred embodiments the basic features and a basic practical implementation are summoned as follows. All embodiments refer to a cartridge device 50 (see
[0087] A first embodiment of a cartridge device 50 of the invention will be described with reference to
[0088] In this embodiment the receiving cavity 16 consists of a cavity within the cartridge device 50. The sample liquid 1 can be applied by means of a syringe, pipette etc, e.g. through a self sealing cap shown as a receiving cavity cover 33a in
[0089] In an alternative embodiment the reagent cavity 19 is integral formed with the pump means 18 and/or with the measurement cavity 20 and/or with the ductwork. The transport of the sample liquid 1 can be controlled by said control apparatus.
[0090]
[0091] It is apparent to a person skilled in the art that in order to achieve a maximum benefit for a user different types of tests can be combined in one cartridge device 50.
[0092] In a preferred embodiment the cartridge device 50 comprises four arrangements of
[0093] Regarding e.g. blood coagulation there are different reagents available which activate or suppress different parts of the coagulation cascade. Pentapharm GmbH (Munich, Germany) for example amongst others provide tests for intrinsic and extrinsic activation of a blood sample (INTEM or EXTEM respectively), and also a test for extrinsic activation in which the thrombocyte function is suppressed by administration of cytochalasin D (FIBTEM). It is state of the art that it is possible by wise combination of such tests to be able to determine very precisely at which point within the coagulation cascade a problem occurs. This is of great importance in order to determine a proper medication. By comparison of the results on an EXTEM test of a pathologic sample to those of a FIBTEM test of the same sample it is possible to e.g. precisely determine if a coagulation disorder results from lack of fibrinogen or a malfunction of platelets. Generally, there are different typical medical scenarios in which coagulation disorders are very likely to occur. For example coagulation disorders occurring during liver transplantation are merely caused by lack of certain coagulation factors etc., while coagulation disorders during open heart surgery are most likely due to the influence of heparin. This means basically that different medical settings require different coagulation tests. Referring to
[0094] It is important to note that the cartridge devices 50 of the described embodiments are suitable for different diagnostic tests like thromboelastometry, thromboelastography, platelet aggregometry and others. Depending on which type of test or tests the cartridge device 50 is designed for, there are different additional parts required which interact with the sample during measurement and/or an external control apparatus. Possible adaptations for thromboelastometry and platelet aggregometry are described below.
[0095]
[0096] The probe element 22 comprises the probe pin 3 (see
[0097] The probe element 22 is arranged in the measurement cavity 20 of the cartridge body 30 of the cartridge device 50 as shown in
[0098] During attaching the cartridge device 50 to the measuring system 40 (see also
[0099] It is also possible to insert the insert section 6a of the shaft 6 into the connector section 26 of the probe element 22 and push the probe element 22 down until its bottom contacts the bottom of the measurement cavity 20, 20 ensuring that the insert section 6a is completely inserted into the connector section 26. Then the shaft 6 will be moved up into the measuring resp. working position of the probe element 22 as shown in
[0100]
[0101] Now a third embodiment of the cartridge device 50 will be described with reference to
[0102]
[0103] The cartridge device 50 of this example is equipped with the ductwork 13 and 15. The ducts are formed with an diameter of approximately 1 mm in this embodiment. The ductwork requires that the cartridge device 50 comprises two parts: the cartridge body 30 and the cover 31, which are glued or welded together to obtain a leak-proof device. The cartridge body 30 is relative rigid and the cover 31 is formed as an elastic part. So it is possible to integrate the pump means 18 into the cover 31. Moreover, the cover 31 covers the receiving cavity 16 with the receiving cavity cover 33a and forms a type of liner wall 33 and a separation wall 34 forming an inlet for the inlet duct 13 within the receiving cavity 16. The receiving cavity cover 33a might act as a self seal for injection of a sample liquid 1 by a syringe for example. The cover 31 forms top parts of the ductwork 13 an 15 and a cover of the measurement cavity 20 (see also
[0104] In this embodiment a reagent cavity 19, 19 is formed, e.g. by sections of the ductwork or/and the pump means 18, 18 in which the reagents can be stored resp. deposited, especially on the pump cavity bottom 36a, for example.
[0105] The pump means 18 will now be described with reference to
[0106]
[0107] In this example the pump cavity 36 is connected to the inlet duct 13 via an inlet valve 37 and to the outlet valve via an outlet valve 38. Actuation of the pump membrane 35 (shown in
[0108] An external force exerted on the pump membrane 35 increase the pressure within the pump cavity 36 and opens outlet valve 38 and closes inlet valve 37. Releasing the external force the elastic pump membrane 35 returns into the position shown in
[0109] Now the measuring system 40 according to the invention is described in an embodiment with reference to
[0110]
[0111] The measuring system 40 comprises an interface element 41 to which the cartridge device 50 is attached and fixed. The interface element 41 is shown in
[0112]
[0113] Thus it is possible to e.g. arrange a reagent receptacle 19b in a blister receptacle e.g. as shown in
[0114] It is also possible to insert reagent receptacles into provided cavities being connected to the ductwork. The reagents can be designed as globules with an appropriate diameter so that they cannot flow through openings into the ductwork before being dissolved by the sample liquid.
[0115]
LIST OF REFERENCE NUMERALS
[0116] 1 Sample liquid [0117] 2 Cup [0118] 3 Probe pin [0119] 4 Torsion wire [0120] 5 Rotation axis [0121] 6 Shaft [0122] 6a Insert section [0123] 7 Bearing [0124] 8 Mirror [0125] 9 Spring [0126] 10 Detecting means [0127] 11 Base plate [0128] 12 Cup holder [0129] 13, 13 Inlet duct [0130] 14, 14 Intermediate duct [0131] 15, 15 Outlet duct [0132] 16, 16 Receiving cavity [0133] 17 Branch duct [0134] 18, 18 Pump means [0135] 19,19 Reagent cavity [0136] 19a, 19a Regent cavity bottom [0137] 19b Reagent receptacle [0138] 20, 20 Measurement cavity [0139] 21, 21 Reagent [0140] 22, 22 Probe element [0141] 23 Intermediate section [0142] 24 Flange [0143] 25 Fixing section [0144] 26 Connector section [0145] 27 Insertion guide [0146] 28 Groove [0147] 29 Dimple [0148] 29a Nose [0149] 30 Cartridge body [0150] 31 Cover [0151] 32 Fixing means [0152] 32a Opening [0153] 33 Wall [0154] 33a Receiving cavity cover [0155] 34 Separation wall [0156] 35 Pump membrane [0157] 36 Pump cavity [0158] 36a Pump cavity bottom [0159] 37 Inlet valve [0160] 38 Outlet valve [0161] 39 Flow direction [0162] 40 Measuring system [0163] 41 Interface element [0164] 42 Pump access [0165] 43 inlet opening [0166] 44 Shaft passage [0167] 44a Passage hole [0168] 45 Reagent cover opening [0169] 46 Retaining ring [0170] 47 Frame [0171] 48 Bottom foil [0172] 49 Blister cover [0173] 50 Cartridge device